| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | David H. Raulet | Q51794345 |
| Stephan Gasser | Q55278807 | ||
| P433 | issue | 5 | |
| P921 | main subject | DNA damage | Q5205747 |
| P304 | page(s) | 344-347 | |
| P577 | publication date | 2006-07-07 | |
| P1433 | published in | Seminars in Cancer Biology | Q1908668 |
| P1476 | title | The DNA damage response, immunity and cancer | |
| P478 | volume | 16 |
| Q37028006 | ATM activation mediates anticancer immunosurveillance by natural killer and T cells |
| Q53323922 | ATM in oral carcinogenesis: association with clinicopathological features. |
| Q34660118 | ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells |
| Q36373362 | An ENU mutagenesis approach to dissect "self"-induced immune responses: Unraveling the genetic footprint of immunosurveillance |
| Q34361976 | An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation |
| Q54858643 | Antigenotoxic Effect of Trametes spp. Extracts against DNA Damage on Human Peripheral White Blood Cells. |
| Q34402066 | Benzo pyrene-induced DNA adducts and gene expression profiles in target and non-target organs for carcinogenesis in mice |
| Q37403182 | Chlorogenic acid prevents isoproterenol-induced DNA damage in vascular smooth muscle cells |
| Q34595104 | Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer |
| Q37404156 | Controlling natural killer cell responses: integration of signals for activation and inhibition |
| Q36939423 | DNA damage response and development of targeted cancer treatments |
| Q39037081 | DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies |
| Q51057019 | Deficient innate immunity, thymopoiesis, and gene expression response to radiation in survivors of childhood acute lymphoblastic leukemia. |
| Q28854563 | Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function |
| Q41144456 | Differential expression profile analysis of DNA damage repair genes in CD133+/CD133- colorectal cancer cells |
| Q37257026 | Essential role of the Ly49A stalk region for immunological synapse formation and signaling |
| Q47101400 | Exosomal microRNA remodels the tumor microenvironment |
| Q37235006 | Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors |
| Q42025977 | How to develop better screens for anti-cancer therapies? |
| Q38156891 | How virus persistence can initiate the tumorigenesis process |
| Q36178400 | Immune microenvironment in tumor progression: characteristics and challenges for therapy |
| Q36771770 | Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns |
| Q92710342 | Induction of NKG2D ligand expression on tumor cells by CD8+ T-cell engagement-mediated activation of nuclear factor-kappa B and p300/CBP-associated factor |
| Q34989590 | Interplay between DNA repair and inflammation, and the link to cancer |
| Q88550356 | Low dose gemcitabine increases the cytotoxicity of human Vγ9Vδ2 T cells in bladder cancer cells in vitro and in an orthotopic xenograft model |
| Q34804590 | MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript |
| Q36118020 | Microenvironment abnormalities and lymphomagenesis: Immunological aspects. |
| Q102057122 | NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis |
| Q54234609 | NKG2D and Its Ligands: "One for All, All for One". |
| Q49724715 | Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review. |
| Q92921946 | Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer |
| Q42796257 | New prospects on the NKG2D/NKG2DL system for oncology |
| Q38860610 | Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors |
| Q34174006 | On the traces of XPD: cell cycle matters - untangling the genotype-phenotype relationship of XPD mutations |
| Q33987633 | Oncogene withdrawal engages the immune system to induce sustained cancer regression |
| Q37279471 | P2X(7) receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin |
| Q37618815 | P2X7-mediated chemoprevention of epithelial cancers |
| Q92395369 | Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial |
| Q50954794 | Profiling DNA damage and repair capacity in sea urchin larvae and coelomocytes exposed to genotoxicants. |
| Q36793616 | Prospects for the use of NK cells in immunotherapy of human cancer. |
| Q53025681 | Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response. |
| Q34407976 | RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma |
| Q37279475 | Regulation of P2X(7) gene transcription |
| Q38108820 | Regulation of self-ligands for activating natural killer cell receptors |
| Q49221858 | Sensing Bacterial-Induced DNA Damaging Effects via Natural Killer Group 2 Member D Immune Receptor: From Dysbiosis to Autoimmunity and Carcinogenesis |
| Q35832525 | Slp-76 is a critical determinant of NK-cell mediated recognition of missing-self targets |
| Q37877269 | Stimulating natural killer cells to protect against cancer: recent developments. |
| Q60489434 | Stress gets under your skin |
| Q38005176 | Targeting NKG2D in tumor surveillance |
| Q60914167 | The Adaptive Complexity of Cancer |
| Q39038723 | The DNA damage response induces antigen presenting cell-like functions in fibroblasts. |
| Q34806981 | The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition. |
| Q36677608 | The anticancer immune response: indispensable for therapeutic success? |
| Q34487363 | The oxidative demethylase ALKBH3 marks hyperactive gene promoters in human cancer cells |
| Q45784223 | Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families |
| Q34719398 | Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease |
| Q57457570 | Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response |
| Q37148659 | Use of gene expression profiles of peripheral blood lymphocytes to distinguish BRCA1 mutation carriers in high risk breast cancer families. |
| Q36693887 | p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK. |
Search more.